Cargando…

Autoantibodies against the β(3)-Adrenoceptor Protect from Cardiac Dysfunction in a Rat Model of Pressure Overload

β(3)-adrenoceptors (β(3)-ARs) mediate a negative inotropic effect in human ventricular cardiomyocytes, which is opposite to that of β(1)- and β(2)-ARs. It has been previously demonstrated that autoantibodies against the β(1/)β(2)-AR exist in the sera of some patients with heart failure (HF) and thes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jin, Li, Meixia, Ma, Xiurui, Bai, Kehua, Wang, Li, Yan, Zi, Lv, Tingting, Zhao, Zhiqing, Zhao, Rongrui, Liu, Huirong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795652/ https://www.ncbi.nlm.nih.gov/pubmed/24147120 http://dx.doi.org/10.1371/journal.pone.0078207

Ejemplares similares

Proliferation in cardiac fibroblasts induced by β(1)-adrenoceptor autoantibody and the underlying mechanisms
por: Lv, Tingting, et al.
Publicado: (2016)

Decreased autophagy induced by β(1)-adrenoceptor autoantibodies contributes to cardiomyocyte apoptosis
por: Wang, Li, et al.
Publicado: (2018)

Macrophage polarization is involved in liver fibrosis induced by β (1)-adrenoceptor autoantibody : β (1)-Adrenoceptor autoantibody and liver fibrosis
por: Wu, Ye, et al.
Publicado: (2022)

Autoantibodies to the β (1)-Adrenoceptor from Patients with Periodontitis as a Risk Factor for Cardiac Dysfunction
por: Segovia, Marcela, et al.
Publicado: (2011)

Autoantibodies Against β(1)‐Adrenoceptor Exaggerated Ventricular Remodeling by Inhibiting CTRP9 Expression
por: Du, Yunhui, et al.
Publicado: (2019)

Autoantibodies against β(1)-adrenoceptor induce blood glucose enhancement and insulin insufficient via T lymphocytes
por: Gong, Yulin, et al.
Publicado: (2015)

Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor
por: Zhang, Wei-Wei, et al.
Publicado: (2017)

Autoantibody against β(1)-adrenoceptor promotes the differentiation of natural regulatory T cells from activated CD4(+) T cells by up-regulating AMPK-mediated fatty acid oxidation
por: Xu, Wenli, et al.
Publicado: (2019)

Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy
por: Ma, Sai, et al.
Publicado: (2021)

S100a9 inhibits Atg9a transcription and participates in suppression of autophagy in cardiomyocytes induced by β(1)-adrenoceptor autoantibodies
por: Zhi, Xiaoyan, et al.
Publicado: (2023)

Decreased autophagy: a major factor for cardiomyocyte death induced by β(1)-adrenoceptor autoantibodies
por: Wang, L, et al.
Publicado: (2015)

C-C chemokine receptor 5 signaling contributes to cardiac remodeling and dysfunction under pressure overload
por: Wang, Xiaomin, et al.
Publicado: (2021)

Mitochondrial Ultrastructural Alterations and Declined M(2) Receptor Density Were Involved in Cardiac Dysfunction in Rats after Long Term Treatment with Autoantibodies against M(2) Muscarinic Receptor
por: Zhang, Suli, et al.
Publicado: (2015)

Alpha-ketoglutarate ameliorates pressure overload-induced chronic cardiac dysfunction in mice
por: An, Dongqi, et al.
Publicado: (2021)

Difference between beta1-adrenoceptor autoantibodies of human and animal origin—Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology
por: Wenzel, Katrin, et al.
Publicado: (2018)

Pressure Overload-induced Cardiac Remodeling and Dysfunction in the Absence of Interleukin 6 in Mice
por: Lai, N. Chin, et al.
Publicado: (2012)

Lionheart LincRNA alleviates cardiac systolic dysfunction under pressure overload
por: Kuwabara, Yasuhide, et al.
Publicado: (2020)

β(1)-Adrenoceptor Autoantibodies from DCM Patients Enhance the Proliferation of T Lymphocytes through the β(1)-AR/cAMP/PKA and p38 MAPK Pathways
por: Du, Yunhui, et al.
Publicado: (2012)

Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure
por: Jin, Li, et al.
Publicado: (2018)

Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice
por: Goh, Kah Yong, et al.
Publicado: (2019)

Relationship between the Autoantibody and Expression of β(3)-Adrenoceptor in Lung and Heart
por: Miao, Guobin, et al.
Publicado: (2013)

VEGF‐C/VEGFR‐3 axis protects against pressure‐overload induced cardiac dysfunction through regulation of lymphangiogenesis
por: Lin, Qiu‐Yue, et al.
Publicado: (2021)

Serum Positive for the Autoantibody against the β (1)-Adrenoceptor from Chinese Patients with Congestive Heart Failure Decreases I (ss) in Mouse Cardiac Myocytes
por: Wang, Yuan-yuan, et al.
Publicado: (2011)

The Natural Product Zerumbone Suppresses Pressure Overload-Induced Cardiac Dysfunction by Inhibiting Cardiac Hypertrophy and Fibrosis
por: Tojima, Mikuto, et al.
Publicado: (2021)

NLRP3-mediated pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin
por: Yue, Rongchuan, et al.
Publicado: (2021)

Chronic intermittent hypoxia accelerates cardiac dysfunction and cardiac remodeling during cardiac pressure overload in mice and can be alleviated by PHD3 overexpression
por: Xu, Xuan, et al.
Publicado: (2022)

Celecoxib prevents pressure overload‐induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress
por: Zhang, Chi, et al.
Publicado: (2015)

Resveratrol ameliorates cardiac dysfunction induced by pressure overload in rats via structural protection and modulation of Ca(2+) cycling proteins
por: Dong, Qi, et al.
Publicado: (2014)

Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, and Fibrosis Induced by Pressure Overload
por: Zhou, Heng, et al.
Publicado: (2011)

Sodium (±)‐5‐bromo‐2‐(α‐hydroxypentyl) benzoate ameliorates pressure overload‐induced cardiac hypertrophy and dysfunction through inhibiting autophagy
por: Wang, Bo, et al.
Publicado: (2019)

Microtubule Stabilization in Pressure Overload Cardiac Hypertrophy
por: Sato, Hiroshi, et al.
Publicado: (1997)

iNOS aggravates pressure overload-induced cardiac dysfunction via activation of the cytosolic-mtDNA-mediated cGAS-STING pathway
por: Guo, Yongzheng, et al.
Publicado: (2023)

Right Ventricular Dysfunction and Failure in Chronic Pressure Overload
por: Simon, Marc A., et al.
Publicado: (2011)

Aerobic Exercise Attenuates Pressure Overload-Induced Cardiac Dysfunction through Promoting Skeletal Muscle Microcirculation and Increasing Muscle Mass
por: Yuan, Ling-Yan, et al.
Publicado: (2021)

Hydrogen-containing saline alleviates pressure overload-induced interstitial fibrosis and cardiac dysfunction in rats
por: Yang, Jing, et al.
Publicado: (2017)

The Ablation of VEGFR-1 Signaling Promotes Pressure Overload-Induced Cardiac Dysfunction and Sudden Death
por: Tirronen, Annakaisa, et al.
Publicado: (2021)

Intermedin Suppresses Pressure Overload Cardiac Hypertrophy through Activation of Autophagy
por: Chen, HuaLi, et al.
Publicado: (2013)

Semaphorin3A Exacerbates Cardiac Microvascular Rarefaction in Pressure Overload‐Induced Heart Disease
por: Li, Chaofu, et al.
Publicado: (2023)

Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via β3-AR-nNOS-NO activation
por: Wang, Bin, et al.
Publicado: (2017)

C‐C Motif Chemokine Receptor 9 Exacerbates Pressure Overload–Induced Cardiac Hypertrophy and Dysfunction
por: Xu, Zhengxi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c0pa44n97tq59m8r8fcc67dsnh